Skip to main content
Home
 
 
 
MENU
Home
Janssen’s COVID-19 Vaccine Status >

Janssen Global Main Menu

  • Our Company
    • About Us
    • Contact Us
    • Grants & Giving
    • News Center
    • Our Leaders
    • Patient Safety information
    • Products
    • Sustainability
    • Transparency
    • VISIT JANSSEN IN YOUR COUNTRY
  • Our Focus
    • Therapeutic Areas
    • Cardiovascular, Metabolism and Retina
    • Immunology
    • Infectious Diseases & Vaccines
    • Neuroscience
    • Oncology
    • Pulmonary Hypertension
    • Patient Engagement
  • Our Science
    • Our Response to COVID-19
    • Clinical Trials
    • Compassionate Use & Pre-Approval Access
    • R&D Data Science
    • Janssen Global Trial Finder
    • World Without Disease Accelerator
    • Janssen Clinical Innovation
    • Precision Medicine & Janssen Diagnostics

Our Stories List

Making a Splash for Disease Awareness
Global_Trial_Finder
Making a Splash for Disease Awareness
Looking Under the Hood for Green Chemistry Solutions
Global_Trial_Finder
Looking Under the Hood for Green Chemistry Solutions
  • RETURN TO HOME

Global Trial Finder

  • text size

My Saved Trials

Loading…
We will use the location information you provide to find the clinical trials taking place close to you in accordance with our Privacy Policy. We do not store this data.
2 Trials found in 110 locations
Filters Clear Filters
Find trials accepting male participants Find trials accepting female participants
Gender
Under 18 years old 18 years or older
Age
Distance Away (mi)(km)
Currently Recruiting

redo search as i move the map

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to list: click to see trial.

View Map Legend
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

1.
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer (MoonRISe-3)
  • Non-Muscle Invasive Bladder Neoplasms

city
distance

  • All
  • 18+ years
  • Not yet recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

2.
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) (SunRISe-5)
  • Non-Muscle Invasive Bladder Neoplasms

city
distance

  • All
  • 18+ years
  • Recruiting
  • 25320 Little Rock, United States
  • 25321 Los Alamitos, United States
  • 25322 Orange, United States
  • 25323 Torrance, United States
  • 25324 Lakewood, United States
  • 25325 Riverview, United States
  • 25326 Chicago Ridge, United States
  • 25327 Carmel, United States
  • 25328 Jeffersonville, United States
  • 25329 Wichita, United States
  • 25330 Royal Oak, United States
  • 25331 Saint Louis, United States
  • 25332 Syracuse, United States
  • 25333 Cincinnati, United States
  • 25334 Gahanna, United States
  • 25335 Bala-Cynwyd, United States
  • 25336 Myrtle Beach, United States
  • 25337 North Charleston, United States
  • 25338 Nashville, United States
  • 25339 Austin, United States
  • 25340 Dallas, United States
  • 25341 Houston, United States
  • 25342 Spokane, United States
  • 25343 Buenos Aires, Argentina
  • 25345 Cordoba, Argentina
  • 25352 Barretos, Brazil
  • 25353 Bauru, Brazil
  • 25355 Porto Alegre, Brazil
  • 25356 Sao Paulo, Brazil
  • 25358 Beijing, China
  • 25359 Cheng Du Shi, China
  • 25360 Chong Qing, China
  • 25362 Shen Yang Shi, China
  • 25363 Tianjin, China
  • 25365 Wenzhou, China
  • 25366 Wuhan, China
  • 25367 XI An Shi, China
  • 25372 Halle (Saale), Germany
  • 25373 Köln, Germany
  • 25374 Leverkusen, Germany
  • 25375 Lubeck, Germany
  • 25376 Mettmann, Germany
  • 25378 Arezzo, Italy
  • 25379 Ravenna, Italy
  • 25380 Roma, Italy
  • 25381 Rozzano, Italy
  • 25382 Torino, Italy
  • 25385 Hyogo, Japan
  • 25386 Niigata, Japan
  • 25387 Okayama, Japan
  • 25388 Sakura, Japan
  • 25389 Tokyo, Japan
  • 25390 Yokohama, Japan
  • 25391 Chungcheongbuk Do, South Korea
  • 25392 Daegu, South Korea
  • 25393 Gyeonggi-do, South Korea
  • 25394 Jeollanam-do, South Korea
  • 25395 Seoul, South Korea
  • 25398 Yangsan-si, South Korea
  • 25403 Torun, Poland
  • 25405 Wroclaw, Poland
  • 25411 Madrid, Spain
  • 25412 Málaga, Spain
  • 25413 Sabadell, Spain
  • 25414 London, United Kingdom
  • 25415 Salford, United Kingdom
  • 25416 Southampton, United Kingdom
  • 25417 Stevenage, United Kingdom
  • 34011 Los Angeles, United States
  • 34012 San Francisco, United States
  • 34013 Chicago, United States
  • 34014 Charleston, United States
  • 34017 Mar del Plata, Argentina
  • 34019 Campinas, Brazil
  • 34020 Curitiba, Brazil
  • 34021 Salvador, Brazil
  • 34026 Macerata, Italy
  • 34027 Milano, Italy
  • 34031 Hakodate, Japan
  • 34032 Bialystok, Poland
  • 34034 Krakow, Poland
  • 34035 Lublin, Poland
  • 34037 Badalona, Spain
  • 34038 Barcelona, Spain
  • 34040 Santander, Spain
  • 34041 Sevilla, Spain
  • 34042 Valencia, Spain
  • 36646 Brugge, Belgium
  • 36647 Bruxelles, Belgium
  • 36648 Genk, Belgium
  • 36649 Gent, Belgium
  • 36650 Roeselare, Belgium
  • 36651 Guang Zhou Shi, China
  • 36652 Lille, France
  • 36653 Limoges, France
  • 36654 Marseille, France
  • 36655 Paris, France
  • 36656 Quint-Fonsegrives, France
  • 36657 Rennes, France
  • 36658 Suresnes, France
  • 36659 Munchen, Germany
  • 36660 Funabashi shi, Japan
  • 36662 Bydgoszcz, Poland
  • 36663 Przemysl, Poland
  • 36664 Tarnow, Poland
  • 36665 Wieliszew, Poland
  • 36666 Brasov, Romania
  • 36667 Bucuresti, Romania
  • 36668 Cluj-Napoca, Romania
  • 36670 Timisoara, Romania

Footer

  • PRIVACY POLICY
  • LEGAL NOTICE
  • COOKIE POLICY
  • COOKIE SETTINGS
  • CAREERS
  • NEWS CENTER
  • DO NOT SELL MY PERSONAL INFORMATION

Footer Social

Find Janssen Global on:

twitter youtube linkedin

Janssen Global Policy text

©Johnson & Johnson Innovative Medicine. All Rights Reserved. This website is hosted and operated by Johnson & Johnson Innovative Medicine, which is solely responsible for its content. This website is intended for a global audience.